Navigation Links
Experimental RNA-based drug kills prostate cancer cells effectively and safely

Acting as a genetic Trojan horse, an experimental RNA-based drug -- the first of its kind -- tricks its way into prostate cancer cells and then springs into action to destroy them, while leaving normal cells unarmed.

The drug, developed at Duke University Medical Center, uses one type of genetic material, called targeting RNA, to enter cancer cells, and another type, called silencing RNA, to stop the expression of a protein that keeps the cells alive.

In tests in mice with prostate cancer, the drug shrank the size of their tumors by half, while the tumors in control mice that did not receive the drug continued to grow, said study co-author Bruce Sullenger, Ph.D., director of Duke's Translational Research Institute and chief of the Division of Experimental Surgery.

The mice showed no side effects from the treatment, Sullenger said.

"This study represents the first step in creating an RNA-based drug for cancer," said lead author James McNamara, Ph.D. a postdoctoral fellow in experimental surgery. "It provides a 'proof of principle' that an entirely RNA-based drug can work with minimal side effects, and it shows it is possible to overcome many of the obstacles that have hampered the development of RNA-based drugs."

The study is reported in the August 2006 issue of Nature Biotechnology, which is now available online. The research was funded by the National Institutes of Health.

Duke has filed a provisional patent application on the technology, according to the researchers.

"Scientists have made numerous attempts to transform silencing RNAs into natural anticancer agents, but such development has been challenging," said Paloma Giangrande, Ph.D., co-leader of the study and an assistant research professor in experimental surgery.

Scientists have encountered major obstacles when trying to deliver silencing RNAs to tumors, Giangrande said. Previous RNA-based drugs have been nonspecific, targeting all cel
'"/>

Source:Duke University Medical Center


Page: 1 2

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. Experimental shingles vaccine proves effective in nationwide study
3. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
4. Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
5. Experimental drug reverses key cognitive deficits, pathology in Alzheimers
6. Experimental vaccine protects lab animals against several strains of H5N1
7. Experimental vaccine protects mice against deadly 1918 flu virus
8. Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy
9. Experimental vaccine given during pregnancy reduces stillbirths from common virus
10. Study: Harmless virus kills some cancers
11. VCU study shows hormone-like molecule kills cells that cause inflammation in allergic disease

Post Your Comments:
(Date:11/19/2009)...tries of the world. It is widely used for human co...It also is considered an exemplar plant species fo... genome architecture. The authors of the research ...t description of the B73 maize genome to probe som... plant biology. The ten papers consider maize cent...
(Date:11/19/2009)... multi-institutional effort co-led by three Cold S...ed today in publication of a landmark series of pa...dented detail the DNA sequence of maize ( Zea mays...rth American consumers, is one of the world,s most...al crop grown in the United States, representing $...
(Date:11/19/2009)...swire-FirstCall/ -- BIO-key International, Inc. (O...lic safety and finger-based biometric identificati...er Meeting held today was adjourned without any ac... ,, (Logo: http://www.newscom.com/cgi-bin/prnh....3% of the 35 million votes cast voted in favor of...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Finally The Round Diet 21 A Diet Simple Enough that Even a Kindergartener Can Follow It 50523 1Finally The Round Diet 21 A Diet Simple Enough that Even a Kindergartener Can Follow It 50523 2WellPoint Recovers and Saves 2475 Million Through Anti Fraud Programs and Investigations in 2008 50521 1WellPoint Recovers and Saves 2475 Million Through Anti Fraud Programs and Investigations in 2008 50521 2WellPoint Recovers and Saves 2475 Million Through Anti Fraud Programs and Investigations in 2008 50521 3Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 1Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 2Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 3Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 4Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops 50519 5
...t suffering from depression. Children take on an e...t and for other family members. It is therefore im...s and have support functions in place for the whol...This is the conclusion of a thesis from the Sahlgr... Registered Nurse Britt Hedman Ahlstrm has examin...
...daq: AWRE ), a leading supplier of broadband tec...hat its Board of Directors has approved a modified...00 shares, or approximately 15%, of its outstandin... share purchase rights), at a price in the range o...e purchase price of approximately $9.1 million. T...
...man, co-author of the study titled "Drought Sensit... of the TEAM Network at Conservation International...ing on energy security and food security, this stu...tem security in short, how nature keeps us health... problem; drying climate is just as bad or worse f...
Other Biology News:Children seriously affected when a parent suffers from depression 2Aware, Inc. Commences Dutch Auction Tender Offer 2Aware, Inc. Commences Dutch Auction Tender Offer 3Aware, Inc. Commences Dutch Auction Tender Offer 4
(Date:11/19/2009)... InSound is honored by latest award fo... Newark, CA (PRWEB) November 16, 2009 -- Popu...visible” hearing aid from InSound Medical a ...rd in the Health category.    ...ed to reside deep in the hearing canal for up to f...
(Date:11/18/2009)...y personnel need to be able to find explosive mate...em. To aid such searches, the National Institute o...om the Department of Homeland Security, has develo...eference Material (SRM) 2905, Trace Particulate Ex...ay methods, the SRM will be helpful in calibrating...
(Date:11/18/2009)... Vernier,s experience in data analysis combined wi...am kits and curricula provide state-of-the...BEAVERTON, Ore., Nov. 18 Vernier S...l science interfaces, sensors, and software and Bi...urer and distributor of life science research and ...
(Date:11/18/2009)...SISSAUGA, ON, Nov. 18 /PRNewswire-FirstCall/ - YM ...fe sciences product development company that ident...g cancer-related products at various stages of dev...uating nimotuzumab were presented today in a poste... Cancer Therapeutics conference in Boston, Massach...
Breaking Biology Technology:Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3New NIST trace explosives standard slated for homeland security duty 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3
...enosumab is a new drug being,studied to prevent fr...al,therapy. Results of a phase 3 clinical trial us... San Antonio Breast Cancer Symposium by Georgiana,... Denosumab is a highly specific antibody that int...zed cells that break down bone. Because it is,high...
...ontinuing Interest in Peregrine,s Anti-PS Technolo... -, TUSTIN, Calif., Dec. 14 Peregrine,Pharmaceut...pharmaceutical,company developing monoclonal antib...virus (HCV) infection, today announced the sudden ...ract award with the Defense Threat,Reduction Agenc...
...l Potential Uses, Excluding U.S. and Japan, No Ot...ase BASINGSTOKE, England and PHILADELPHIA, Decemb...Q),the global specialty biopharmaceutical company,...e rights, excluding the U.S. and Japan, to AT-1001...1 is Alba,s lead inhibitor,of barrier dysfunction ...
Other Biology Technology:New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment 2Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program 2Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program 3Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program 4Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation 2Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation 3
Bovine IgG2 ELISA Kit from Bethyl Laboratories
Dog IgE ELISA Kit from Bethyl Laboratories
PCP ELISA Kit, Single from Bio-Quant Inc.
...opment ,Antibody Titer and Optimal Conditions Anal... and Tissues ,Double Antibody Labeling of Cells an...ogold, and Fluorescent detection ,Light, Fluoresce...n Transgenic Animals ,Hundreds of Specialty Marker...
Biology Products: